Chronic Renal Insufficiency and Renal Replacement Therapy Flashcards
Definition of CKD
Progressive, IRREVERSIBLE renal impairment > 3 months as evidenced by:
- GFR <60 ml/min/1.73m2
OR
- albuminuria (AER >30mg/day or ACR >3mg/mmol)
==> permanent destruction of nephrons and reduction of GFR with loss of tubular and glomerular functions
Causes of CKD
Diabetic nephropathy (30%)
Hypertension (25%)
Glomerulonephritis (15%)
Pathophysiology of CKD
Intact Nephron Hypothesis
- reduction of number of WHOLE NEPHRONS
- the other remaining surviving nephrons are functional
Adaptations to CKD
In order to continue to excrete the daily load of a given substance
- usually at CKD stage 3/4 but fails at stage 5
Adaptation of kidney
- extent of reabsorption and excretion
Adaptation of substrates
Adaptation of Substrates: principle and effects on creatinine
Limitation of output = transient fall in outflow rate which raises fluid levels in body –> until a new steady state is achieved where output is restored to match input
PASSIVE maintenance of balance and homeostasis (input = output)
Creatinine: no homeostasis (plasma [Cr] stable initially then increase exponentially)
Adaptation of Kidney: those with stable levels until very ESRD
Amino acids and glucose: complete reabsorption of filtered substances (plasma concentration remains unchanged)
Na: can increase FENa to >5% (reduce reabsorption; plasma concentration unchanged until very low GFR of 2-3 ml/min and >130 mmol salt intake)
- mediated by ANP
- can’t tolerate sudden change in salt intake (narrow range of Na excretion)
K: enhanced secretion gradually (not dependent on GFR in early CKD; normal plasma concentrations until ESRD e.g. GFR <10 –> decreased flow rate)
- mediated by aldosterone
Adaptation of Kidney: H+
Slightly earlier derangement e.g. GFR <20
H+: decreased NH3 production due to smaller kidney mass ==> decreased total H+ excretion ==> metabolic acidosis
- increase tubular secretion (down to pH 4.5), increase regeneration of HCO3
- NAGMA at early stage, HAGMA at later stage
Effects of metabolic acidosis:
- utilise bone buffer to control acidosis –> osteodystrophy
- adaptive increase in NH3 per nephron leads to tubulointersitital damage
- skeletal muscle breakdown, decreased albumin synthesis
Adaptation of Kidney: Ca and PO4
Also earlier derangement (like H+)
Decreased nephron mass = PO4 retention
PO4 response to CKD similar to Cr –> increase [PO4]p when GFR decreases
–> leads to decreases [Ca]p which stimulates PTH response
==> Ca and PO4 maintained normal/slightly elevated by increasing PTH in early CKD (secondary hyperPTH)
Late CKD:
- reabsorption of PO4 reaches the minimum of 15% (can’t excrete more)
- persistent hyperPO4 and hypoCa develops
- decreased 1 alpha-hydroxylation of vitamin D –> decreased [Ca]p and reduced suppression of PTH
“vitamin D resistance” towards 25-OH Vit D
==> renal osteodystrophy (prevent with Vitamin D)
- osteomalacia (defective mineralisation)
- osteitis fibrosa cystica (PTH stimulated osteoclastic activity)
- osteosclerosis (metastatic calcification due to poor treatment; rare now)
(new finding that FGF23 is a key regulator of PO4 homeostasis; increase a/w mortality in CKD)
Renal handling of water
Defects in concentrating ability due to:
- low medullary hypertonicity
- medullary fibrosis
- collection tubule resistance to ADH
(scarring = medulla distorted and counter-circulation loop distorted so can’t concentrate)
==> urine Osm reaches isotonic (300 mmol/L) hence minimum output becomes 4L/day
Clinical features:
- isosthenuria
- polyuria
- nocturia
- edema, volume expansion (due to solute retention in ESRD when max urine volume limited by GFR <10 and can’t achieve obligatory solute loss)
Clinical course of CKD (4 stages)
75-50% function
- reduced renal reserve
- no detectable azotaemia (urea and creatinine normal)
- asymptomatic
50-25% function
- renal insufficiency
- mild azotaemia (elevated urea and creatinine)
- HT and anaemia, developing urinary concentrating defect (polyuria)
25-12% function (15-30 ml/min)
- renal failure
- hypoCa, hyperPO4, mild metabolic acidosis
- advancing anaemia (less EPO), advancing HT and isosthenuria
<12% (<15 ml/min)
- uraemia
- marked azotaemia and worsening acidosis
- electrolyte disorders become apparent
- multisystem disorders “uraemia syndrome”
Conservative Mx
keep balance and slow down rate of progression to ESRD
- prevent further insult to kidney
- prevent and promptly treat acute complications
- prevent development of bone disease
- quality of life
Dialysis definition and indications
Differential transfer of solutes and water, by diffusion, osmosis or ultrafiltration, through a semipermeable membrane
Indication:
- GFR <10 ml/min
- symptoms/signs of renal failure e.g. pruritus, acid-base/ electrolyte disturbance
- inability to control volume status or blood pressure
- progressive deterioration in nutritional status refractory to dietary intervention
- cognitive impairment
Types of Renal replacement therapy
Haemodialysis
- diffusion through artificial membrane in dialyser
- create arteriovenous fistula with arterial blood out to filtrate and back to vein after
- 80-160 ml/min
Peritoneal dialysis (intermittent or continuous ambulatory)
- fluid into peritoneal cavity
- diffusion through peritoneal membrane to “soak up” excess waste and solutes from blood
- takes 12 hrs (rate of 15-20 ml/min)
Haemofiltration
- convection through highly permeable membrane and replaced by fluid of desired composition
Renal transplant